James Marion

James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Rewalk Robotics Ltd (NASDAQ:RWLK) Pricing Public Offering at Discount

Rewalk Robotics Ltd (NASDAQ:RWLK)

Rewalk Robotics Ltd (NASDAQ:RWLK) fell 14.8% after announcing the pricing of a public offering of 6.9 million shares at $1.05 a share. The developer of wearable robotic exoskeletons has also granted underwriters a 45-day option for the purchase of an additional 1 million shares. Currently, there are 25.91 million shares of RWLK outstanding. Accordingly, the public offering will have a materially dilutive effect on shareholder equity – a fact that likely fueled the sell-off.

Rewalk Robotics Ltd (NASDAQ:RWLK)

The offering should close on or about November 21, 2017. Rewalk Robotics Ltd (NASDAQ:RWLK) plans to use net proceeds for sales, marketing, and reimbursement expenses related to market development activities. Part of the funds are also to be used for research and development costs, related to the development of a lightweight soft-suit exoskeleton technology for various lower limb disabilities.

Rewalk Robotics Ltd (NASDAQ:RWLK) is closing in on its all-time lows after remaining under pressure for the better part of the year. The stock is down by more than 50% for the year as it continues to trade in a strong downtrend. Immediate support is at the $1.15 mark, below which the stock could register a new 52-week low.

Rewalk Q3 Financial Results

Investor’s confidence in the stock has taken a hit after Rewalk Robotics Ltd (NASDAQ:RWLK) reported a net loss of $5.8 million for the three months ended September 30, 2017. During the quarter, revenues grew 24% to $1.7 million and by 46% to $6.2 million for the first nine months of the year. Gross Margin in the quarter improved to 41% from 21% reported last year.

In defense of the company’s long-term prospects, Chief Executive Officer Larry Jasinski believes the company is on course for further growth.

“Our business continues to deliver year over year growth as we focus on advancing our key initiatives including insurance reimbursement coverage for the ReWalk Personal device and progressing our innovative soft suit exoskeleton technology, the Restore, designed for individuals who experienced a stroke,” said Mr. Jasinski.

Rewalk Robotics Ltd (NASDAQ:RWLK) has already begun pre-clinical testing of its Restore System as it seeks to evaluate its safety, as well as ability to address mobility needs for stroke patients. A clinical trial for the system is planned for the first quarter of next year with commercialization in Europe set for late 2018.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $RWLK and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Catalyst Biosciences Inc (NASDAQ:CBIO) shares have come off their early morning high of $9.00, bounced off $5.50 level and now trading above $6 handle.

Catalyst Biosciences Inc (NASDAQ:CBIO) Sees Morning Volatility

Catalyst Biosciences Inc (NASDAQ:CBIO)

Catalyst Biosciences Inc (NASDAQ:CBIO) shares have come off their early morning high of $9.00, bounced off the 45.50 level and are now trading above the $6 handle. Volume, as of 10 AM EST, is already at 1.2 million shares. CBIO shares have a listed daily average of just over 271,000. The company has released no news, or made any filings, that could account for the morning’s volatility.

Catalyst Biosciences Inc (NASDAQ:CBIO)

Catalyst Biosciences Inc. (NASDAQ:CBIO) is a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia. Catalyst’s most advanced program is a potent next-generation coagulation Factor VIIa variant, marzeptacog alfa (activated), that has successfully completed an intravenous Phase 1 clinical trial in individuals with severe hemophilia A or B.

CBIO Stock

In February, Catalyst Biosciences Inc. (NASDAQ:CBIO) underwent a reverse stock split to stay in compliance with NASDAQ rules regarding low priced stock. Dilution has been an issue for shareholders of CBIO. In 2013, there were 20,000 shares outstanding. By the end of 2016 that number had ballooned to 780,000.

Sales have also been going in the wrong direction. In 2012 Catalyst reported sales of $57.9 million. However, that figure was just $400,000 for FY 2016. On a diluted adjusted basis, EPS loss for 2013 was -$409.30. That loss shrank steadily and the EPS loss for CBIO was -$21.75 for 2016.

Of particular note is that the company reports a cash per share value of $6.35. Shares are trading around that level this morning. Analysts have given CBIO shares a rating of “Strong Buy”. Their consensus, one-year price target is $12.33.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CBIO and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Nova Lifestyle Inc (NASDAQ:NVFY) Jumps in Pre-Market on Guidance

Nova Lifestyle Inc (NASDAQ:NVFY)

Shares of Nova Lifestyle Inc (NASDAQ:NVFY) are up over 20% in the pre-market after the company provided financial guidance for Q4 2017. The pre-market low of $1.92 was hit at 7:45 AM EST, and the pre-market high was established at 7:53 AM EST at $2.38. Volume has been light to moderate.

Nova Lifestyle Inc (NASDAQ:NVFY) forecasted revenues to come in between $35 and $36 million. Net income guidance was$3 million – $3.5 million. Net income, per share, is expected to be in the range of $0.11 – $0.13 for the quarter. And, notably, Nova announced that it expects expanded profit margins across nearly all product lines.

Tawny Lam, CEO of Nova Lifestyle Inc (NASDAQ:NVFY) stated “Since the Company’s successful transformation in early 2017 from a low-margin furniture manufacturing business to a high-margin innovative designer and global marketer of modern lifestyle consumer products, we have significantly fine-tuned our product mix and deepened distribution channels, which led to our recently announced record 3rd quarter financial results.”

“Nova made over $1 million in net income during the month of October, a substantial increase over the same period last year. Nova expects the same growth momentum to continue for the balance of the 4th quarter of 2017 and well into 2018.”

Nova LifeStyle Business Model

Nova Lifestyle Inc (NASDAQ:NVFY) is headquartered in Commerce, California. The company designs, manufactures, and distributes modern LifeStyle furniture – primarily sofas, dining rooms, cabinets, office furniture and related components, bedrooms, and various accessories in matching collections. Nova’s products are made and marketed in the US, Europe, and Asia and include LifeStyle brands such as Diamond Sofa, Nova QwiK, and Bright Swallow International.

NVFY Stock Performance

Nova Lifestyle Inc (NASDAQ:NVFY) broke above strong resistance at $2 last week, sold off, then broke above the key threshold again yesterday. NVFY has a 52-week low of $1.06 and a 52-week high of $3.13.

Over the past quarter, the stock has outperformed, gaining over 30%. However, over the past year, NVFY stock has lost over 40%. Recently the company has been trading near it book/share value of $2.28. What is interesting is that listed reports have Nova Lifestyle’s cash per share at just $0.01.

Sales have not impressed over the last few years. In 2014, sales were reported at $98.7 million and that decreased to $92.6 million by 2016. Earnings have also been challenging. In 2014 EPS was at $0.42, but in 2016 the company posted a per share loss of (-$0.01).

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $NVFY and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Diana Containerships Inc (NASDAQ:DCIX)

Stock Rises Despite Q3 Losses by Diana Containerships Inc (NASDAQ:DCIX)

Diana Containerships Inc (NASDAQ:DCIX)

Diana Containerships Inc (NASDAQ:DCIX) shares are up 81%, to $12, in pre-market trading after the shipping company reported a Q3 2017 loss of $8.7 million. On a per-share basis, the loss amounted to $128.67. DCIX shares, a favorite of day-traders, hit a low of $6.35 at 7:13 AM EST and a high of $9.50 at 7:56. Volume has been light to moderate.

Diana Containerships Inc (NASDAQ:DCIX)

The shipping company posted revenue of $6.7 million in the period. Greece-based Diana Containerships Inc (NASDAQ:DCIX) is a global shipping provider. The company’s containerships are employed primarily on time charters with leading liner companies carrying containerized cargo along worldwide shipping routes.

Diana Q3 Financials

Net income for the nine months ended September 30, 2017 amounted to $20.4 million, compared to a net loss of (-$140.6) million for the same period of 2016. The net income for the nine months ended September 30, 2017 reflected a gain from a debt write-off, arising from the settlement agreement with respect to the secured loan facility with the Royal Bank of Scotland plc. The specific gain, net of related expenses, amounted to $42.2 million.

The loss for the nine months ended September 30, 2016 reflected the result of impairment charges for seven of the company’s vessels. Time charter revenues, net of prepaid charter revenue amortization, for the nine months ended September 30, 2017, amounted to $16 million, compared to $27.7 million for the same period in 2016.

Diana Lawsuit

A number of law firms are pursuing class action lawsuits against Diana Containerships Inc (NASDAQ:DCIX). The complaints generally allege that the company made materially false and misleading statements regarding the company’s business, operational, and compliance policies.

Specifically, the company made false and/or misleading statements and/or failed to disclose that: (i) through his control of Diana, Symeon Palios caused Diana to sell its common shares and securities convertible into common shares to an entity named Kalani Investments Limited (“Kalani”) at a significant discount to market price and to file registration statements so that Kalani could resell these shares into the market; (ii) when Kalani’s sales of DCIX stock caused the price of Diana stock to drop, the company would reverse split the stock, causing a specific number of outstanding shares to be merged into a single share, thereby raising the price of Diana stock; (iii) then Diana would again sell securities to Kalani and the same pattern of transactions would ensue.

By October 3, 2017, as a result of defendants’ ongoing dilutive and manipulative conduct, the price of Diana common stock had declined to close at $0.47 per share on an unadjusted basis. At this share price, Diana had a market capitalization of less than one million dollars, despite having raised millions of dollars since January 2017.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $DCIX and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) Market Value Almost Triples!

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) Market Value Almost Triples!

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC)

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) shares nearly tripled in market value after the holding company reported Q3 financial results that exceeded Wall Street expectations. Revenue for the three months ended September 30, 2017, nearly doubled as net loss dropped by two thirds.

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) Market Value Almost Triples!

CADC Stock Performance

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) stock is currently trading at this year’s highs and close to its 52-week high of high of $9.75 a share. The better than expected financial results appear to have strengthened investor confidence in the company, as the stock had been trading in a downtrend.

Over the past one month, the stock has performed along a premium change of 7.5%. For the past three months, the stock is up by more than 13.1%. However, it is down by 6.5% for the past six months.

The stock grabbed analysts’ attention after spiking on unusual volume. More than 19.31 million shares exchanged hands in Thursday’s trading session compared to a 3-month average volume of 0.02 million and a daily average trading volume of 15.5k shares.

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) conducts its primary business through subsidiaries. The company engages in the production of construction materials for infrastructure, commercial and residential developments.

Government and industry associations have certified the company’s products. It also boasts of a leading position in the large, highly fragmented ready-mix market concrete market.

CADC Q3 Financial Results

For the three months ended September 30, 2017, the construction company reported revenues of $13.8 million, up from revenues of $7.5 million reported in the corresponding period last year. Cost of revenue surged to $12.3 million from $8.41 million. China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) generated a gross profit of $1.4 million compared to $952,412 reported last year.

“Our management believes that we have the ability to capture a greater share of the Beijing market via expanding relationships and networking, signing new contracts, and continually developing market-leading innovative and eco-friendly ready-mix concrete products,” China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) in a statement.

Net loss for the three months ended September came in at $545,590 compared to a net loss of $5.3 million reported last year. China Advanced Construction Materials exited the quarter with cash and cash equivalent of $923,882 compared to $8.2 million as of the same period last year.

China Advanced Constructn Mtrls Grp Inc. (NASDAQ:CADC) has a Return on Assets of -25.40%. Return on Investment currently stands at -20.55 which means its operations costs outweigh returns.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CADC and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Liquidmetal Technologies Inc. (OTCMKTS:LQMT)

Liquidmetal Technologies Inc. (OTCMKTS:LQMT) Touts Production Milestones

Liquidmetal Technologies Inc. (OTCMKTS:LQMT)

Shares of Liquidmetal Technologies Inc. (OTCMKTS:LQMT) gained 10.8% after the amorphous alloy developer said it achieved major production milestones in the medical and automotive markets in Q3. During the quarter, the company demonstrated its new ENGEL-based medical grade molding system and upgraded EON industrial grade molding systems.

Liquidmetal Technologies Inc. (OTCMKTS:LQMT)

Financial Results/ Corporate Update

Focus in the quarter was on the development of prototype and commercial parts for customers. Liquidmetal Technologies Inc. (OTCMKTS:LQMT) also partnered licensees on the development of the company’s technology and production processes.

“Our customers have shifted from an interest in a novel technology to a strong desire to produce high volumes of amorphous metal parts. We now have the capabilities customers demand to scale high-value production,” said Bruce Bromage, COO.

It awaits to be seen if the milestones will help strengthen investors’ confidence in Liquidmetal Technologies Inc. (OTCMKTS:LQMT). The stock has been under pressure since September when it rose to $0.40 a share. While the stock is up by more than 10% for the year, it faces the risk of dropping further as it continues to trade near a key support level.

For the third quarter, Liquidmetal Technologies Inc. (OTCMKTS:LQMT) generated revenues of $36,000. Selling, marketing, general, and administrative expenses in the quarter totaled $1.7 million as research and development expenses dropped to $500,000 from $548,000 as of last year.

The company exited the quarter with cash and cash equivalent of $43.3 million compared to $58.9 million as of December 31, 2016. Liquidmetal Technologies Inc. (OTCMKTS:LQMT) attributes the decrease to capital expenditures associated with the build-out of the company’s manufacturing capabilities.

LiquidMetal COO Appointment

Separately, Liquidmetal Technologies Inc. (OTCMKTS:LQMT) has confirmed the appointment of Bruce Bromage as the company’s Chief Operating Officer. Bromage is tasked with the responsibility of executing the company’s business strategy and operations.

He takes over after serving as the company’s executive vice president of business development and operations. Bromage has previously held executive positions at Hewlett Packard and the Hughes Aircraft Company. According to the Chief Executive Officer, the appointment provides direct accountability for the company’s operational financial performance.

Open House Event

The developer of alloy technologies hosted an open house event at its Lake Forest facility last month. Over 180 investors, customers, and partners attended the event. On display were the firm’s three production lines, medical-grade amorphous metal molding, and industrial grade amorphous metal molding and newly added Metal injection molding.

“It was a pleasure to be able to discuss our business directly with customers and investors,” said Professor Li. “They had many excellent questions.”

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $LQMT and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Sorl Auto Parts, Inc. (NASDAQ:SORL) Raises Guidance after Stellar Q3

Sorl Auto Parts, Inc. (NASDAQ:SORL)

Shares of Sorl Auto Parts, Inc. (NASDAQ:SORL) gained 20.4% after the leading manufacturer and distributor of automotive brake systems reported Q3 financial results that beat Wall Street estimates. According to the Chief Executive Officer, Xiaoping Zhang, demand for the company’s products continue to increase across all three business segments.

Sorl Auto Parts, Inc. (NASDAQ:SORL)

Sorl Sales Growth

Investors reacted to the better than expected financial results by pushing the stock up the chart, after coming under pressure in recent weeks. The stock is currently trading in an uptrend with immediate resistance at $8.40, above which it could make a push for the 52-week high of $9.74 a share. For the full year, the stock is up by more than 90%.

For the three months ended September 30, 2017, Sorl Auto Parts, Inc. (NASDAQ:SORL) generated sales of $101.3 million – representing a 59% year over year growth. Revenues from international markets increased 19.1% to $19.3 million due to growing global customer base. Net sales for the first nine months of the year increased 29.6% to $72.9 million.

Gross profit in the quarter grew 44.4% to $27.3 million compared to $18.9 million reported last year. However, gross margin dropped to 26.9% from 29.7% due to higher raw materials costs and price promotion designed to increase market share.

“We are excited to report that our sales growth in all three segments accelerated during the quarter. We continue to capture market share in the Chinese commercial vehicle braking market with our new advanced products and attractive pricing,” said Mr. Zhang.

New Guidance

Net income attributed to shareholders increased 165% to $8.6 million or $0.44 a share compared to $3.2 million or $0.17 a share reported last year. Net income for the first nine months of the year nearly doubled to $21.4 million or $1.11 a share from $10.9 million or $0.57 a share reported last year.

Sorl Auto Parts, Inc. (NASDAQ:SORL) exited the third quarter with cash and cash equivalent of $7.6 million. Inventories in the quarter increased to $83.1 million from $65.8 million as of December 31, 2018.

Buoyed by the strong performance in the third quarter, Sorl Auto Parts, Inc. (NASDAQ:SORL) management has increased its full-year guidance for net sales, from $315 million to approximately $370 million. The company also expects net income of $30.5 million up from an initial guidance of $27.5 million.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $SORL and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Why Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Jumped

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) shares closed up 10%, and had two closing days above the $2 level for the first time since May of 2017. The catalyst for the stock’s upward momentum, on a day when markets sold off, seems to be an article authored by a CFA specializing in the biotech space. The analyst rates the shares a “Buy”.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is a biopharmaceutical company that develops and commercializes therapies to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. Anthera has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients suffering from Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis.

Analysts on Anthera

Three analysts follow Anthera Pharmaceuticals Inc (NASDAQ:ANTH). One rates ANTH as a “Strong Buy”, while the other two rate the shares as a “Hold”. The analysts have a consensus, one-year price target of $2.00 on the shares – $0.31 below today’s close. For FY2017, analysts are projecting an EPS loss of (-$3.34).

ANTH Stock Performance

For the year, ANTH stock is down over 85%. However, the shares are up 45% for the past month.

In 2015, Anthera posted sales of $3.2 million but for 2016 the figure was a disappointing $100,000. Earnings have been disappointing as well. In 2012, the biotech firm reported an earnings loss of (-$50.19). The next year the loss was (-$13.52), followed in 2014 by a loss of (-$10.88), then (-$7.91) for 2015, and in 2016, the loss was (-$12.87).

There are a number of short-sellers on ANTH stock. Their short positions represent 15% of the stock’s float.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $ANTH and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Netlist, Inc. (NASDAQ:NLST)

Netlist, Inc. (NASDAQ:NLST) Stock Craters on Decision

Netlist, Inc. (NASDAQ:NLST)

Netlist, Inc. (NASDAQ:NLST) stock cratered after two decisions by two different courts gave the chip manufacturer a win and a loss. NLST shares were down over 50% by the close of business today to close at $0.24 on a volume over 24 times its listed daily average.

Netlist, Inc. (NASDAQ:NLST)

Court of Appeals Decision

Yesterday, the U.S. Court of Appeals for the Federal Circuit affirmed earlier decisions from the U.S. Patent Trial and Appeal Board (PTAB) confirming the validity of certain claims of Netlist’s U.S. Pat. Nos. 8,001,434 (434 Patent) and 8,359,501 (501 Patent).

Netlist’s 434 Patent and 501 Patent cover self-test technologies widely used in LRDIMMs, SSDs, and Storage Class Memory. Netlist, Inc. (NASDAQ:NLST) asserted these patents as part of a seven-patent lawsuit against SanDisk and Diablo Technologies.  SanDisk and Smart Modular filed a total of six petitions for Inter Partes Review (IPR) challenging the validity of these two patents, which have now been resolved in Netlist’s favor by the Federal Circuit. If they so choose, the decision can be appealed to the U.S. Supreme Court.

U.S. International Trade Commission Finding

However, Netlist, Inc. (NASDAQ:NLST) also lost its case when the Administrative Law Judge Bullock of the United States International Trade Commission (ITC), issued a Notice of Initial Determination (ID) in its investigation of SK hynix RDIMM and LRDIMM enterprise memory products. According to the notice, ALJ Bullock determined that no violation of section 337 of the Tariff Act has been found with respect to Netlist’s patents in Certain Memory Modules and Components Thereof, and Products Containing Same, Investigation No. 337-TA-1023.

The parties and their counsel have not yet received the full ID, which is subject to confidentiality restrictions. Netlist anticipates its counsel will receive this document within the next few days.  Netlist will determine at that time whether further comment on the decision is appropriate.  A public version of the ID will be available within 30 days.

The ID is now subject to review by the Commissioners at the ITC. Netlist, Inc. (NASDAQ:NLST) intends to petition for review of any findings in the ID it believes are incorrect.  The Commission will then decide whether to review portions of, or the entire ID.  Once the issues under review have been briefed, the Commission may affirm, set aside, or modify the portions of the ID under review.  These conclusions will be contained in a Final Determination which is currently scheduled to be issued by the Commission by March 14, 2018.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $NLST and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Energy XXI Gulf Coast Inc. (NASDAQ:EXXI)

Energy XXI Gulf Coast Inc. (NASDAQ:EXXI) Drops on Wider Net Loss

Energy XXI Gulf Coast Inc. (NASDAQ:EXXI)

Shares of Energy XXI Gulf Coast Inc. (NASDAQ:EXXI) fell 34.3% after the oil and natural gas exploration and production company reported disappointing third quarter financial results. A net loss of (-$31.6) million or (-$0.95) loss per share, attributed to lower production and losses on derivative financial instruments, did not go well with investors.

Energy XXI Gulf Coast Inc. (NASDAQ:EXXI)

EXXI Stock Performance

Tuesday’s sell-off resulted in Energy XXI Gulf Coast Inc. (NASDAQ:EXXI) recording a new 52-week low of $5.32 a share as the stock’s downturn shows no signs of slowing down. The stock has underperformed the overall industry for the better part of the year even as the energy sector shows signs of recovery. For the full year, the stock is down by more than 80% as it continues to trade in a strong downtrend.

Energy XXI Gulf Coast Inc. (NASDAQ:EXXI) underperformance has already caught the attention of analysts. According to data compiled by Zacks Investment Research, analysts are forecasting earnings increase of 0% this year, over last year. Next year earnings on the other hand should increase 21.1%

Total revenues for the third quarter totaled $117 million inclusive of a $12.5 million loss on derivative financial instruments. Second quarter revenues totaled $143.7 million. Total LOE in the quarter was $77.8 million per BOE, made up of $64.3 million in lease operating expense. According to the Chief Executive Officer, Douglas E. Brooks, reduction of LOE and G&A costs resulted in a 45% improvement in adjusted EBITDA quarter over quarter.

Commodity Hedging

The natural gas exploration and development company entered into fixed price swap contracts benchmarked to NYMEX-WTI to hedge 8,000 BOPD of production for the full year. The swap contracts are priced at $50.68. The company also has fixed price swap contracts benchmarked to LLS-Argus for 2,000 BOPD with an average fixed price of $55.45 for the January to June 2018 period.

Energy XXI Gulf Coast Inc. (NASDAQ:EXXI) is currently working with its financial advisors on it’s long-term strategic plan focused on the Gulf of Mexico consolidation

“Since no executable combination has resulted from these discussions, we are now focused on our stand-alone options, which include a drilling program beginning in early 2018. This activity in 2018 and beyond may be funded internally through existing liquidity, the benefit of higher oil prices, and continued progress on reducing costs,” said Mr. Douglas E. Brooks.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $EXXI and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.